药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Prazepam
Seocalcitol
The serum concentration of Magnesium can be increased when it is combined with Seocalcitol.
Thyroglobulin
Alaproclate
The risk or severity of serotonin syndrome can be increased when Alaproclate is combined with Lithium carbonate.
Thyroglobulin
Ritanserin
The risk or severity of serotonin syndrome can be increased when Ritanserin is combined with Lithium carbonate.
Thyroglobulin
Indalpine
The risk or severity of serotonin syndrome can be increased when Indalpine is combined with Lithium carbonate.
Thyroglobulin
Desvenlafaxine
The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Lithium carbonate.
Thyroglobulin
Milnacipran
The risk or severity of serotonin syndrome can be increased when Milnacipran is combined with Lithium carbonate.
Thyroglobulin
Seproxetine
The risk or severity of serotonin syndrome can be increased when Lithium carbonate is combined with Seproxetine.
Thyroglobulin
Dapoxetine
The risk or severity of serotonin syndrome can be increased when Lithium carbonate is combined with Dapoxetine.
Thyroglobulin
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Lithium carbonate is combined with Oliceridine.
Thyroglobulin
Mebutizide
The serum concentration of Lithium carbonate can be increased when it is combined with Mebutizide.
Thyroglobulin
Magnesium
The serum concentration of Magnesium can be increased when it is combined with Lithium carbonate.
Thyroglobulin
Polymyxin B
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with Polymyxin B.
Thyroglobulin
Esketamine
The risk or severity of adverse effects can be increased when Lithium carbonate is combined with Esketamine.
Thyroglobulin
2,5-Dimethoxy-4-ethylthioamphetamine
The therapeutic efficacy of 2,5-Dimethoxy-4-ethylthioamphetamine can be decreased when used in combination with Lithium carbonate.
Thyroglobulin
Gepefrine
The therapeutic efficacy of Gepefrine can be decreased when used in combination with Lithium carbonate.
Thyroglobulin
Methoxyphenamine
The therapeutic efficacy of Methoxyphenamine can be decreased when used in combination with Lithium carbonate.
Thyroglobulin
Mephedrone
The therapeutic efficacy of Mephedrone can be decreased when used in combination with Lithium carbonate.
Thyroglobulin
Ritobegron
The therapeutic efficacy of Ritobegron can be decreased when used in combination with Lithium carbonate.
Thyroglobulin
Iofetamine I-123
The therapeutic efficacy of Iofetamine I-123 can be decreased when used in combination with Lithium carbonate.
Thyroglobulin
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Lithium carbonate.